IRIS
MICALE, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.603
EU - Europa 1.412
AS - Asia 1.397
SA - Sud America 355
AF - Africa 157
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 6.929
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.454
SG - Singapore 602
CN - Cina 538
IT - Italia 431
IE - Irlanda 359
BR - Brasile 306
UA - Ucraina 158
CA - Canada 128
CI - Costa d'Avorio 107
RU - Federazione Russa 107
DE - Germania 61
VN - Vietnam 59
KR - Corea 58
IN - India 53
GB - Regno Unito 47
ES - Italia 39
SE - Svezia 39
CZ - Repubblica Ceca 28
FI - Finlandia 28
SN - Senegal 27
NL - Olanda 25
PL - Polonia 19
AR - Argentina 16
TR - Turchia 16
FR - Francia 15
MX - Messico 15
JP - Giappone 13
EC - Ecuador 11
CH - Svizzera 10
BD - Bangladesh 9
ID - Indonesia 9
AT - Austria 7
BE - Belgio 7
CO - Colombia 7
GR - Grecia 7
IQ - Iraq 7
LB - Libano 7
NG - Nigeria 7
ZA - Sudafrica 7
DK - Danimarca 6
VE - Venezuela 6
BG - Bulgaria 5
PK - Pakistan 5
UZ - Uzbekistan 5
EU - Europa 4
AE - Emirati Arabi Uniti 3
HK - Hong Kong 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
AZ - Azerbaigian 2
BB - Barbados 2
BO - Bolivia 2
CL - Cile 2
KE - Kenya 2
KZ - Kazakistan 2
LT - Lituania 2
PE - Perù 2
RS - Serbia 2
AL - Albania 1
AU - Australia 1
BH - Bahrain 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
LV - Lettonia 1
MA - Marocco 1
MU - Mauritius 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
SM - San Marino 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
ZW - Zimbabwe 1
Totale 6.929
Salva come PNG Salva come JPEG
Città #
Santa Clara 757
Dallas 642
Singapore 378
Dublin 341
Chandler 300
Jacksonville 234
Chicago 199
Boardman 139
Hefei 115
Catania 109
Abidjan 107
Cambridge 92
Lawrence 92
Andover 90
Nanjing 85
Toronto 82
Des Moines 64
Seoul 58
Ashburn 57
Los Angeles 47
Beijing 44
Houston 40
Civitanova Marche 35
Nanchang 32
Hebei 30
Messina 28
Ottawa 28
Dakar 27
Hyderabad 25
Rome 24
Saint Petersburg 24
São Paulo 23
New York 22
Shenyang 22
Tianjin 22
Changsha 21
Prague 21
Munich 20
Jiaxing 19
Amsterdam 18
Council Bluffs 18
San Mateo 18
Wilmington 18
Barcelona 17
Ho Chi Minh City 17
Brooklyn 15
Hanoi 14
Columbus 12
Lappeenranta 12
The Dalles 12
Tokyo 11
Warsaw 11
Zhengzhou 10
Florence 9
Jinan 9
San Francisco 9
Atlanta 8
Seattle 8
Abuja 7
Augusta 7
Belo Horizonte 7
Brussels 7
Dong Ket 7
Moscow 7
Phoenix 7
Turku 7
Berlin 6
Boston 6
Denver 6
Guangzhou 6
Helsinki 6
Istanbul 6
Madrid 6
Manchester 6
Mumbai 6
Redwood City 6
Rio de Janeiro 6
Aci Catena 5
Bremen 5
Chennai 5
Foggia 5
Hangzhou 5
Johannesburg 5
London 5
Montreal 5
Ningbo 5
Ribeirão Preto 5
Secaucus 5
Tübingen 5
Baghdad 4
Brasília 4
Curitiba 4
Dhaka 4
Falls Church 4
Grafing 4
Guarulhos 4
Guayaquil 4
Irvine 4
Jakarta 4
Krakow 4
Totale 4.967
Salva come PNG Salva come JPEG
Nome #
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 118
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant 108
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems 107
The beta3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes 107
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia 102
Fluoxetine Protects Retinal Ischemic Damage in Mice 96
Behavioral effects of dietary cholesterol in rats tested in experimental models of mild stress and cognition tasks 96
Different effects of prenatal MAM vs. perinatal THC exposure on regional cerebral blood perfusion detected by Arterial Spin Labelling MRI in rats 93
Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets 91
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels 91
Altro che Marijuana i molteplici ruoli delle sostanze cannabinoidi endogene 90
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 90
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: analyses in patients and perinatal Δ9-tetrahydrocannabinol-exposed rats 89
Systemic depletion of histone macroH2A1.1 boosts hippocampal synaptic plasticity and social behavior in mice 89
Endocannabinoids and neurodegenerative diseases 86
Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats 86
Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions 86
Behavioral effects of the β3 adrenoceptor agonist SR58611A: Is it the putative prototype of a new class of antidepressant/anxiolytic drugs? 86
Beavioral effects of SR 58611A, a beta-3 agonist, on experimental models of mild stress 85
Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade 84
Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels 84
The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology 83
Attuali orientamenti terapeutici della malattia di Parkinson 81
Amnesia induced by beta-amyloid peptide in dopamine D3 knock-out (KO) mice Is affectedby a cannabinoid CB1 receptor antagonist 80
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis 79
Behavioral modifications induced by dietary cholesterol in rats 79
Early modulation of the endocannabinoid tone prevents molecular and behavioral alterations in MAM model of schizophrenia 78
Behavioral and pharmacokinetic profile of indole-derived synthetic cannabinoids JWH-073 and JWH-210 as compared to the phytocannabinoid 19-THC in rats 78
The cannabinoid CB1 antagonist TM38837 with limited penetrance to the brain shows reduced fear-promoting effects in mice 78
The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated rats 77
Behavioral and molecular effects of repeated treatment with citalopram alone or combined with memantine in rats 77
Behavioral effects of ABIO 09/01, a CaMKII inhibitor, on experimental models of depression and anxiety 76
Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia 76
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicity 75
Cannabinoid CB1 receptor blockade effects memory capacity of dopamine D3 KO mice pre-treated with β-amyloid peptide 72
Effects of citalopram combined with memantine in forced swimming test in rats 70
Melatonin affects the immobility time of rats in the forced swim test: The role of serotonin neurotransmission 69
2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons 69
Dopamine D(3) receptor knock-out mice exhibit increased behavioral sensitivity to the anxiolytic drug diazepam 68
Therapeutic potential of cannabinoids in schizophrenia 68
Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats 66
Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment 66
“Prescription pattern of antiepileptics in primary care in Italy upon recognition of new indications for reimbursement“. 65
Cannabidiol and the central nervous system: translating into clinics 64
Long-lasting neurotoxicity of prenatal benzene acute exposure in rats 64
Biocompatibility of a genetically encoded calcium indicator in a transgenic mouse model 64
HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia-like animals 64
Red Flags in Primary Mitochondrial Diseases: What Should We Recognize? 63
D3 dopamine receptor knockout mice: behavioral alteration in experimental models of anxiety 63
Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia 63
Sex Differences in the Reinstatement of Methamphetamine Seeking after Forced Abstinence in Sprague-Dawley Rats 62
Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia 62
A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia 62
Use of phenylethanolaminotetralines for preparing anxiolytic drugs 62
Extinction of avoidance behavior by safety learning depends on endocannabinoid signaling in the hippocampus 61
Role of the endocannabinoid system and vanilloid TRPV1 channels in the phenotype of dopamine D3 receptor knock-out mice 60
Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon? 60
Dual effects of melatonin on barbiturate-induced narcosis in rats 60
Involvement of NK2 receptors in experimental models of anxiety and depression under basal and stress-related conditions 60
Vitamin D and depression in women: a mini-review 60
Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: Obligatory role of hippocampal GPR55 receptors 59
Dopaminergic drugs may counteract behavioral and biochemical changes induced by models of brain injury 59
Prenatal Exposure to Δ9-Tetrahydrocannabinol Affects Hippocampus-Related Cognitive Functions in the Adolescent Rat Offspring: Focus on Specific Markers of Neuroplasticity 58
Increased sensitivity to antidepressants of D(3) dopamine receptor-deficient mice in the forced swim test (FST) 58
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms 58
Dysregulation of endocannabinoid system in schizophrenia: the potential role of cannabinoid 1 receptor altered gene expression 58
Topically administered NOX4 inhibitor, GLX7013114, is efficacious in treating the early pathological events of diabetic retinopathy 57
Placebo affects the performance of rats in models of depression: is it a good control for behavioral experiments? 57
The amnesic effects induced by β-amyloidfragment 1–42 involve cannabinoid neurotransmission in the brain 57
Parkin expression profile in dopamine d3 receptor knock-out mice brains 57
Dynamic DNA methylation programs persistent adverse effects of early-life stress 57
Endocannabinoid system and mood disorders: Priming a target for new therapies 56
Endocannabinoid system genes regulation in schizophrenia 56
Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test) 56
Interacting effects of the MAM model of schizophrenia and antipsychotic treatment: Untargeted proteomics approach in adipose tissue 56
Nociceptin/orphanin FQ opioid receptor (NOP) selective ligand MCOPPB links anxiolytic and senolytic effects 56
Prenatal influences facilitate the precipitation of a schizophrenia-like phenotype: assessing the role of the endocannabinoid system 55
Hippocampal neuroplasticity is involved in the antidepressant-like effects of 5HT4 receptor partial agonist SL 65.0155 54
Enhanced cognitive performance of dopamine D3 receptor "knock-out" mice in the step-through passive-avoidance test: assessing the role of the endocannabinoid/endovanilloid systems 54
Lack of interaction of endocannabinoids and 5-HT(3) neurotransmission in associative fear circuits of the amygdala: evidence from electrophysiological and behavioural experiments 54
The beta3 adrenoceptor agonist amibegron counteracts stress-induced behavioural and neurobiological changes 54
Increased levels of conditioned fear and avoidance behavior coincide with changes in phosphorylation of the protein kinase B (AKT) within the amygdala in a mouse model of extremes in trait anxiety 54
DNA methylation at cannabinoid type 1 and dopamine D2 receptor genes in saliva samples of psychotic subjects: Is there an effect of Cannabis use? 53
Leading compounds for the validation of animal models of psychopathology 53
Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia 53
Binge-like alcohol exposure in adolescence: behavioural, neuroendocrine and molecular evidence of abnormal neuroplasticity … and return 53
Olanzapine, but not haloperidol, exerts pronounced acute metabolic effects in the methylazoxymethanol rat model 52
Signaling through cGMP-dependent protein kinase I in the amygdala is critical for auditory-cued fear memory and long-term potentiation 52
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors. 52
Cognitive effects of SL650155, a 5HT4 receptor partial agonist, in animal models of amnesia 52
Memory performance of dopamine D3 knock-out mice (KO) mice pre-treated with beta-amyloid peptide is affected by cannabinoid CB1 receptor antagonist 51
Prolonged fear incubation leads to generalized avoidance behavior in mice 51
Role of the Endocannabinoid System in Depression: from Preclinical to Clinical Evidence 51
Structural and behavioural changes in a rodent developmental disruption model of schizophrenia 51
Endocannabinoid system, stress and HPA axis 51
Early pharmacological modulation of the endogenous cannabinoid signaling counteracts the phenotype in a rodent developmental disruption model of schizophrenia at adulthood 50
Deficiency of histone variant macroH2A1.1 is associated with sexually dimorphic obesity in mice 49
Metabolic profile of methylazoxymethanol model of schizophrenia in rats and effects of three antipsychotics in long-acting formulation 48
Olanzapine, but not haloperiool, improves cognitive performance in an animal model of amnesia induced by β-amyloid peptides 47
Hippocampal expression of BDNF is involved in the behavioral effects of the β3 adrenoceptor agonist, SR58611A 47
Totale 6.804
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.381
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.381
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021306 0 0 0 1 134 9 64 6 21 7 44 20
2021/2022661 91 89 7 23 99 11 95 35 32 2 12 165
2022/20231.050 97 49 12 84 87 186 10 184 262 3 42 34
2023/2024444 31 67 26 32 18 53 4 14 34 17 92 56
2024/20252.327 30 334 127 119 575 352 41 82 162 178 145 182
2025/20261.480 285 192 774 229 0 0 0 0 0 0 0 0
Totale 7.122